ArticleFrontiers in pharmacology2023

Cost-effectiveness of adding empagliflozin to the standard of care for patients with heart failure with reduced ejection fraction from the perspective of healthcare system in Malaysia.

Siew Chin Ong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.